CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 8-K Event Director nominations · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Chief Financial Officer bought 4,902 shares at $2.04 ($10,000)
- 4 Open-market buy Chief Executive Officer bought 12,255 shares at $2.04 ($25,000)
- 4 Open-market buy Director bought 12,255 shares at $2.04 ($25,000)
- 4 Open-market buy Director bought 9,804 shares at $2.04 ($20,000)
- 4 Open-market buy Director bought 4,902 shares at $2.04 ($10,000)
- 4 Open-market buy Director bought 4,167 shares at $2.04 ($8,501)
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- S-1/A Offering Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 74 · 1,465 filings